Evidence map›Paper›PMID 19906512›Full record

ArticleJournal of dermatological science2009

Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.

Margaret S Lee, Mina Yaar, Mark S Eller, Thomas M Rünger, Ying Gao, Barbara A Gilchrest

Abstract read
In one paragraph

Article in Journal of dermatological science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. T-oligo as an anticancer agent in colorectal cancer.Biochemical and biophysical research communications · 2014
    Article
  7. Article
  8. Article
  9. Alternative strategy for Alzheimer's disease: stress response triggers.International journal of Alzheimer's disease · 2012
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Margaret S LeeDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA.
Mina Yaar
Mark S Eller
Thomas M Rünger
Ying Gao
Barbara A Gilchrest
Boston University · US

Funding

PRE- AND POSTDOCTORAL TRAINING IN BIOCHEMISTRY OF AGINGT32AG000115 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI POLGAR, PETER RUDOLPH · 1985 to 2012
$4.3M
Telomere-Mediated Protective Responses in SkinR01CA105156 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILCHREST, BARBARA A · 2004 to 2007
$1.4M
RESEARCH TRAINING PROGRAM IN DERMATOLOGYT32AR007562 · NIAMS · TUFTS MEDICAL CENTER · PI GILCHREST, BARBARA A · 1989 to 2005
$623k
NCI NIH HHS 1 R01 CA 105156NCI NIH HHS R01 CA105156NIAMS NIH HHS T32 AR007562NIAMS NIH HHS T32 AR07562-16NIA NIH HHS T32 AG000115NIA NIH HHS T32 AG00115-17
6 · The paper itself

Abstract

backgroundReactive oxygen species (ROS) are generated by cellular metabolism as well as by exogenous agents. While ROS can promote cellular senescence, they can also act as signaling molecules for processes that do not lead to senescence. Telomere homolog oligonucleotides (T-oligos) induce adaptive DNA damage responses including increased DNA repair capacity and these effects are mediated, at least in part, through p53.

objectiveStudies were undertaken to determine whether such p53-mediated protective responses include enhanced antioxidant defenses.

methodsNormal human fibroblasts as well as R2F fibroblasts expressing wild type or dominant negative p53 were treated with an 11-base T-oligo, a complementary control oligo or diluents alone and then examined by western blot analysis, immunofluorescence microscopy and various biochemical assays.

resultsWe now report that T-oligo increases the level of the antioxidant enzymes superoxide dismutase 1 and 2 and protects cells from oxidative damage; and that telomere-based gammaH2AX (DNA damage) foci that form in response to T-oligos contain phosphorylated ATM and Chk2, proteins known to activate p53 and to mediate cell cycle arrest in response to oxidative stress. Further, T-oligo increases cellular ROS levels via a p53-dependent pathway, and these increases are abrogated by the NAD(P)H oxidase inhibitor diphenyliodonium chloride.

conclusionThese results suggest the existence of innate telomere-based protective responses that act to reduce oxidative damage to cells. T-oligo treatment induces the same responses and offers a new model for studying intracellular ROS signaling and the relationships between DNA damage, ROS, oxidative stress, and cellular defense mechanisms.

Indexed as

TelomereAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineCheckpoint Kinase 2DNADNA-Binding ProteinsDNA DamageDNA RepairFibroblastsHistonesHumansNADPH OxidasesOligonucleotidesOxidative StressProtein Serine-Threonine KinasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsCheckpoint Kinase 2CHEK2 protein, humanDNADNA-Binding ProteinsH2AX protein, humanHistonesNADPH OxidasesOligonucleotidesProtein Serine-Threonine KinasesReactive Oxygen SpeciesTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID19906512
PMCPMC2844100
OpenAlexW2170126051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.